Compare iShares Self-Driving EV and Tech (IDRV) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Self-Driving EV and Tech vs Immunovant Inc. Common Stock — how do they compare? iShares Self-Driving EV and Tech trades at $32.75 (market cap $264.50M), while Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B). The key difference: Immunovant Inc. Common Stock is far larger — about 23.6× iShares Self-Driving EV and Tech's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, iShares Self-Driving EV and Tech nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Self-Driving EV and Tech for 73 Days and Immunovant Inc. Common Stock for 0 Days on average.
| IDRV | IMVT | |
|---|---|---|
Market Cap | $264.50M | $6.25B |
Volume | 48,021 | 1,755,411 |
Sector | Sector/Thematic | Health |
52-Week High | $45.48 | $44.96 |
52-Week Low | $32.68 | $17.03 |
Typical Hold Time | 73 Days | 0 Days |
Enterprise Value | — | $5.35B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares Self-Driving EV and Tech
IDRV invests in global companies at the forefront of self-driving and electric vehicle innovation. It provides exposure to the full EV value chain, including battery technology and autonomous systems, with top holdings like Albemarle, Rivian, and Tesla.
Read more on IDRV →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
